DNA topoisomerase II inhibitors.
出版信息
IARC Monogr Eval Carcinog Risks Hum. 2000;76:175-344.
Abstract
摘要
相似文献
1
DNA topoisomerase II inhibitors.DNA拓扑异构酶II抑制剂
IARC Monogr Eval Carcinog Risks Hum. 2000;76:175-344.
2
Other pharmaceutical agents.其他药剂。
IARC Monogr Eval Carcinog Risks Hum. 2000;76:345-486.
3
Does bulk damage to DNA explain the cytostatic and cytotoxic effects of topoisomerase II inhibitors?
Biochem Pharmacol. 1991 Nov 27;42(12):2253-8. doi: 10.1016/0006-2952(91)90227-v.
4
Mechanisms of action of teniposide (VM-26) and comparison with etoposide (VP-16).替尼泊苷（VM - 26）的作用机制及与依托泊苷（VP - 16）的比较。
Semin Oncol. 1992 Apr;19(2 Suppl 6):3-19.
5
Studies on Non-synonymous Polymorphisms Altering Human DNA Topoisomerase II-Alpha Interaction with Amsacrine and Mitoxantrone: An Approach.非 synonymous 多态性改变人 DNA 拓扑异构酶 II - alpha 与安吖啶和米托蒽醌相互作用的研究：一种方法。
Curr Cancer Drug Targets. 2017;17(7):657-668. doi: 10.2174/1568009617666161109142629.
6
Toxicity of the topoisomerase II inhibitors.拓扑异构酶II抑制剂的毒性
Expert Opin Drug Saf. 2005 Mar;4(2):219-34. doi: 10.1517/14740338.4.2.219.
7
Etoposide: four decades of development of a topoisomerase II inhibitor.依托泊苷：一种拓扑异构酶II抑制剂四十年的发展历程
Eur J Cancer. 1998 Sep;34(10):1514-21. doi: 10.1016/s0959-8049(98)00228-7.
8
9
引用本文的文献
1
Trypanosomatids topoisomerase re-visited. New structural findings and role in drug discovery.锥虫拓扑异构酶再探讨。新的结构发现及其在药物研发中的作用。
Int J Parasitol Drugs Drug Resist. 2014 Aug 24;4(3):326-37. doi: 10.1016/j.ijpddr.2014.07.006. eCollection 2014 Dec.
2
DNA topoisomerases in apicomplexan parasites: promising targets for drug discovery.顶体酶在顶复门寄生虫中的作用：药物研发的有前途的靶点。
Proc Biol Sci. 2010 Jun 22;277(1689):1777-87. doi: 10.1098/rspb.2009.2176. Epub 2010 Mar 3.
3
The benzene metabolite, hydroquinone and etoposide both induce endoreduplication in human lymphoblastoid TK6 cells.苯代谢物对苯二酚和依托泊苷均能诱导人淋巴母细胞TK6细胞发生核内复制。
Mutagenesis. 2009 Jul;24(4):367-72. doi: 10.1093/mutage/gep018. Epub 2009 Jun 2.
Zotero 插件